Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Equality Challenge Unit announced today that the Department of Oncology and the Nuffield Department of Surgical Sciences have been awarded Athena SWAN silver awards for their commitment to advancing women's careers in academia. The Medical Sciences Division now holds 16 silver awards, with all clinical departments holding silver awards. 

Silver Athena SWAN awards are presented by the Equality Challenge Unit in recognition of an organisation’s response to identified challenges and demonstration of the impact of their equality and diversity policies. 

Attaining the silver award is an important milestone working towards equality and diversity.

Nuffield Department of Surgical Sciences Head of Department, Professor Freddie Hamdy, commented: "We are delighted that the department has been awarded an Athena Swan Silver Award. Our goal is to ensure that the department is a place where everyone is given the support and opportunity to achieve their full potential. We are proud of the positive changes within the department and this award reflects our progress on our journey to ensure we provide an inclusive, diverse and world-class department."

Claire Shingler, Operations Manager in the Department of Oncology, said:  “We are delighted to have achieved the Athena SWAN silver award as these issues are extremely important to us. We have some exceptionally talented scientists and non-research staff in the Department of Oncology, many of whom are women, and we want to celebrate their achievements. Nonetheless, we recognise that in order to nurture and grow this talent, we need to constantly strive to offer an inclusive environment in which both women and men want to study and work and where their careers can flourish."

Related Link

NDS receive Athena SWAN silver award

Similar stories

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.